PulmPEEPs 96. Guidelines Series: GINA Guidelines – Asthma Treatment and Management
24 snips
Mar 4, 2025 The hosts delve into the updated GINA Guidelines for asthma management, emphasizing a holistic treatment approach. They highlight effective management strategies, including both pharmacologic and non-pharmacologic techniques. A significant focus is placed on inhaled corticosteroids over short-acting options. The discussion of MART therapy showcases innovative combined inhalers for better patient outcomes. Additionally, they tackle medication dosages and insurance challenges that affect asthma care, stressing the importance of personalized treatment and ongoing patient education.
AI Snips
Chapters
Transcript
Episode notes
Prioritize ICS Therapy
- Prioritize inhaled corticosteroid (ICS)-containing therapies for asthma treatment.
- Over-reliance on short-acting beta-agonists (SABAs) increases exacerbation risks.
SABA Overuse Risks
- Many patients with asthma only use SABA rescue inhalers.
- Regular SABA use is linked to worse outcomes, including reduced responsiveness.
MART Therapy
- Use maintenance and reliever therapy (MART) with a single inhaler containing ICS and formoterol.
- Adjust medication according to symptoms for better control and fewer exacerbations.